Darwin E. Zaske

2.5k total citations
59 papers, 2.0k citations indexed

About

Darwin E. Zaske is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Infectious Diseases. According to data from OpenAlex, Darwin E. Zaske has authored 59 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pharmacology, 11 papers in Pediatrics, Perinatology and Child Health and 8 papers in Infectious Diseases. Recurrent topics in Darwin E. Zaske's work include Antibiotics Pharmacokinetics and Efficacy (28 papers), Antibiotic Resistance in Bacteria (8 papers) and Antimicrobial Resistance in Staphylococcus (7 papers). Darwin E. Zaske is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (28 papers), Antibiotic Resistance in Bacteria (8 papers) and Antimicrobial Resistance in Staphylococcus (7 papers). Darwin E. Zaske collaborates with scholars based in United States and New Zealand. Darwin E. Zaske's co-authors include Ronald J. Sawchuk, Robert J. Cipolle, Richard G. Strate, John C. Rotschafer, Lynn D. Solem, William A. Wargin, Kent Crossley, Randall D. Seifert, Dale N. Gerding and Albert I. Wertheimer and has published in prestigious journals such as JAMA, Neurology and The American Journal of Medicine.

In The Last Decade

Darwin E. Zaske

58 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Darwin E. Zaske United States 22 1.2k 512 374 356 261 59 2.0k
George R. Aronoff United States 32 822 0.7× 293 0.6× 411 1.1× 305 0.9× 135 0.5× 126 3.6k
Thaddeus H. Grasela United States 31 905 0.8× 529 1.0× 461 1.2× 363 1.0× 413 1.6× 100 2.6k
Mario Furlanut Italy 26 1.4k 1.2× 617 1.2× 273 0.7× 702 2.0× 367 1.4× 116 2.7k
Rashmi H. Barbhaiya United States 31 1.3k 1.1× 498 1.0× 363 1.0× 484 1.4× 459 1.8× 137 3.1k
Indravadan H. Patel United States 27 917 0.8× 334 0.7× 610 1.6× 381 1.1× 175 0.7× 75 2.4k
I. Nilsson-Ehle Sweden 24 865 0.7× 357 0.7× 158 0.4× 216 0.6× 318 1.2× 58 1.8k
Frédéric Cotton Belgium 28 815 0.7× 529 1.0× 324 0.9× 282 0.8× 282 1.1× 120 2.3k
Bradley A. Boucher United States 29 588 0.5× 774 1.5× 328 0.9× 223 0.6× 437 1.7× 94 2.4k
Larry A. Bauer United States 25 656 0.6× 241 0.5× 968 2.6× 290 0.8× 76 0.3× 74 2.4k
Daniel P. Healy United States 23 873 0.7× 451 0.9× 151 0.4× 361 1.0× 219 0.8× 62 1.7k

Countries citing papers authored by Darwin E. Zaske

Since Specialization
Citations

This map shows the geographic impact of Darwin E. Zaske's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darwin E. Zaske with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darwin E. Zaske more than expected).

Fields of papers citing papers by Darwin E. Zaske

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Darwin E. Zaske. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darwin E. Zaske. The network helps show where Darwin E. Zaske may publish in the future.

Co-authorship network of co-authors of Darwin E. Zaske

This figure shows the co-authorship network connecting the top 25 collaborators of Darwin E. Zaske. A scholar is included among the top collaborators of Darwin E. Zaske based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Darwin E. Zaske. Darwin E. Zaske is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vance‐Bryan, Kyle, et al.. (1995). Anti-infective agents and hepatic disease. Medical Clinics of North America. 79(4). 895–917. 6 indexed citations
2.
Miller, Todd Q., et al.. (1993). Physiologic response of stress and aminoglycoside clearance in critically ill patients. Critical Care Medicine. 21(2). 248–251. 19 indexed citations
3.
Guay, David R.P., et al.. (1991). Comparison of Pharmacokinetic and Safety Profiles of Amantadine 50‐ and 100‐mg Daily Doses in Elderly Nursing Home Residents. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 11(6). 460–466. 13 indexed citations
4.
Zaske, Darwin E., et al.. (1991). Amikacin Pharmacokinetics: Wide Interpatient Variation in 98 Patients. The Journal of Clinical Pharmacology. 31(2). 158–163. 21 indexed citations
5.
Zaske, Darwin E., et al.. (1991). Initial Dosage Regimens of Gentamicin in Patients with Burns. Journal of Burn Care & Rehabilitation. 12(1). 46–50. 11 indexed citations
6.
Garrison, Mark W., Darwin E. Zaske, & John C. Rotschafer. (1990). Aminoglycosides: Another Perspective. DICP. 24(3). 267–272. 18 indexed citations
7.
Ackerman, Bruce H., et al.. (1990). Thermal Injury Effects on Drug Disposition: A Prospective Study with Piperacillin. The Journal of Clinical Pharmacology. 30(7). 632–637. 9 indexed citations
8.
Weir, Matthew R., et al.. (1987). Sustained-release diltiazem compared with atenolol monotherapy for mild to moderate systemic hypertension. The American Journal of Cardiology. 60(17). 36–41. 21 indexed citations
9.
Mann, Henry J., Daniel M. Canafax, Robert J. Cipolle, et al.. (1985). Increased dosage requirements of tobramycin and gentamicin for treating Pseudomonas pneumonia in patients with cystic fibrosis. Pediatric Pulmonology. 1(5). 238–243. 28 indexed citations
10.
Zaske, Darwin E., et al.. (1982). INCREASED BUM PATIENT SURVIVAL WITH INDIVIDUALIZED DOSAGES OF GENTAMICIN. 91. 142–149. 3 indexed citations
11.
Lesar, Timothy S. & Darwin E. Zaske. (1982). Antibiotics and Hepatic Disease. Medical Clinics of North America. 66(1). 257–266. 3 indexed citations
12.
Fischer, James H., et al.. (1982). Phenobarbital dosing in neonates and asphyxia. Neurology. 32(7). 788–788. 4 indexed citations
13.
Uden, Donald L., et al.. (1981). Saliva-Serum Theophylline Concentrations. Therapeutic Drug Monitoring. 3(2). 143–150. 10 indexed citations
14.
Zaske, Darwin E., et al.. (1981). Increased gentamicin dosage requirements: Rapid elimination in 249 gynecology patients. American Journal of Obstetrics and Gynecology. 139(8). 896–900. 26 indexed citations
15.
Cipolle, Robert J., et al.. (1979). Severe methanol poisoning. The American Journal of Medicine. 67(5). 804–807. 93 indexed citations
16.
Bootman, J. Lyle, Darwin E. Zaske, Albert I. Wertheimer, & Clayton Rowland. (1979). Cost of individualizing aminoglycoside dosage regimens. American Journal of Health-System Pharmacy. 36(3). 368–370. 12 indexed citations
17.
Zaske, Darwin E., Ronald J. Sawchuk, & Richard G. Strate. (1978). The necessity of increased doses of amikacin in burn patients.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 84(5). 603–8. 50 indexed citations
18.
Lott, Rex S., Donald L. Uden, William A. Wargin, Richard G. Strate, & Darwin E. Zaske. (1978). Correlation of Predicted Versus Measured Creatinine Clearance Values in Burn Patients. American Journal of Health-System Pharmacy. 35(6). 717–721. 14 indexed citations
19.
Zaske, Darwin E.. (1977). Oral Aminophylline Therapy. JAMA. 237(14). 1453–1453. 31 indexed citations
20.
Sawchuk, Ronald J. & Darwin E. Zaske. (1976). Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: Gentamicin in burn patients. Journal of Pharmacokinetics and Biopharmaceutics. 4(2). 183–195. 295 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by George R. Aronoff Breakdown of academic impact, for papers by Thaddeus H. Grasela Breakdown of academic impact, for papers by Mario Furlanut Breakdown of academic impact, for papers by Rashmi H. Barbhaiya Breakdown of academic impact, for papers by Indravadan H. Patel Breakdown of academic impact, for papers by I. Nilsson-Ehle Breakdown of academic impact, for papers by Frédéric Cotton Breakdown of academic impact, for papers by Bradley A. Boucher Breakdown of academic impact, for papers by Larry A. Bauer Breakdown of academic impact, for papers by Daniel P. Healy
Rankless by CCL
2026